Treatment Program for Anemia in AIDS Patients
Launched by R W JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE · Aug 30, 2001
Trial Information
Current as of March 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Exclusion Criteria
- Co-existing Condition:
- Patients with the following are excluded:
- • Life expectancy \< 3 months.
- • = or \< grade 4 performance score.
- • AIDS-related dementia.
- • Uncontrolled hypertension.
- • Acute symptomatic opportunistic infection or other AIDS-defining illness.
- Patients with the following are excluded:
- • Life expectancy \< 3 months.
- • = or \< grade 4 performance score.
- • AIDS-related dementia.
- • Uncontrolled hypertension.
- • Acute symptomatic opportunistic infection or other AIDS-defining illness.
- Patients must have:
- • A clinical diagnosis of AIDS.
- • Hematocrit \< 30 percent.
- • Endogenous serum erythropoietin level = or \< 500 U/ml.
- • A life expectancy = or \> 3 months.
- • \> Grade 4 performance score.
About R W Johnson Pharmaceutical Research Institute
The R.W. Johnson Pharmaceutical Research Institute is a leading pharmaceutical research organization dedicated to advancing innovative therapeutic solutions that improve patient outcomes. With a strong focus on drug development and clinical trials, the Institute leverages cutting-edge science and technology to discover and evaluate new treatments across a range of medical conditions. Committed to rigorous research methodologies and ethical standards, R.W. Johnson Pharmaceutical Research Institute collaborates with various stakeholders, including academic institutions and healthcare professionals, to drive progress in the pharmaceutical industry and deliver transformative therapies to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Raritan, New Jersey, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials